Faulty Neulasta Onpro Devices: Billing and Reimbursement Reminders
Posted August 29, 2019
The Neulasta Onpro device makes life a little easier for chemotherapy patients by allowing them to administer the drug Neulasta at home. When a device fails, the patient must go to the doctor’s office for the injection to avoid infection.
As a reminder, if this happens, a failed device may not be reimbursable. Please check with the manufacturer or contact your distributor for information on failed devices and drug waste.
As always, only administered drugs along with appropriately related wastage are eligible for billing. Billing that resembles duplicate payment for a failed device may be indicated on your statement and may be recouped. If this occurs, please contact the manufacturer for possible replacement.
Trademarks are the property of their respective owners.
The material presented here is for informational/educational purposes only, is not intended to be medical advice or a definitive source for coding claims and is not a substitute for the independent medical judgment of a physician or other health care provider. Health care providers are encouraged to exercise their own independent medical judgment based upon their evaluation of their patients’ conditions and all available information, and to submit claims using the most appropriate code(s) based upon the medical record documentation and coding guidelines and reference materials. References to other third party sources or organizations are not a representation, warranty or endorsement of such organization. Any questions regarding those organizations should be addressed to them directly. The fact that a service or treatment is described in this material is not a guarantee that the service or treatment is a covered benefit and members should refer to their certificate of coverage for more details, including benefits, limitations and exclusions. Regardless of benefits, the final decision about any service or treatment is between the member and their health care provider.